$LLY ELI LILLY & Co Insider Trading
Get free email notifications about insider trading in ELI LILLY & Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ELI LILLY & Co. Insider overview, share value development, latest insider transactions and email notifications about new events in ELI LILLY & Co for free.
IRS Number: 350470950
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: LLY
Company Address: LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS 46285
Former name: LILLY ELI & CO, date of change: 1994-10-24
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Market Capitalization: $83.74B
Prev close: $77.70
Average Daily Volume: 6,261,160
Days Low: $77.19
Year Low: $64.18
Year High: $83.79
ELI LILLY & Co Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% Owner | Sell | S | 235.67 | 600 | 141,401 | 109,412,100 | 109.4 M to 109.4 M (0.00 %) |
Jun 11 2021 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% Owner | Sell | S | 235.15 | 42,596 | 10,016,535 | 109,412,700 | 109.5 M to 109.4 M (-0.04 %) |
Jun 11 2021 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% Owner | Sell | S | 233.89 | 57,008 | 13,333,487 | 109,455,296 | 109.5 M to 109.5 M (-0.05 %) |
Jun 11 2021 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% Owner | Sell | S | 233.17 | 120,475 | 28,091,638 | 109,512,304 | 109.6 M to 109.5 M (-0.11 %) |
Jun 11 2021 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% Owner | Sell | S | 232.35 | 19,321 | 4,489,292 | 109,632,779 | 109.7 M to 109.6 M (-0.02 %) |
May 03 2021 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Buy | P | 182.99 | 546 | 99,913 | 61,195 | 60.6 K to 61.2 K (+0.90 %) |
May 03 2021 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Buy | P | 182.74 | 820 | 149,847 | 60,649 | 59.8 K to 60.6 K (+1.37 %) |
Apr 29 2021 | LLY | ELI LILLY & Co | Zakrowski Donald A | Chief Accounting Of ... | Sell | S | 181.38 | 3,000 | 544,140 | 5,987 | 9 K to 6 K (-33.38 %) |
Apr 21 2021 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Grant | A | 189.64 | 10 | 1,896 | 59,829 | 59.8 K to 59.8 K (+0.02 %) |
Apr 21 2021 | LLY | ELI LILLY & Co | JOHNSON KIMBERLY H | Director | Grant | A | 189.64 | 51 | 9,672 | 102 | 51 to 102 (+100.00 %) |
Apr 21 2021 | LLY | ELI LILLY & Co | Alvarez Ralph | Director | Grant | A | 189.64 | 58 | 10,999 | 49,517 | 49.5 K to 49.5 K (+0.12 %) |
Mar 17 2021 | LLY | ELI LILLY & Co | Alvarez Ralph | Director | Grant | A | 189.16 | 58 | 10,971 | 49,459 | 49.4 K to 49.5 K (+0.12 %) |
Mar 17 2021 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Grant | A | 189.16 | 10 | 1,892 | 59,819 | 59.8 K to 59.8 K (+0.02 %) |
Mar 17 2021 | LLY | ELI LILLY & Co | JOHNSON KIMBERLY H | Director | Grant | A | 189.16 | 51 | 9,647 | 51 | 0 to 51 |
Mar 10 2021 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% Owner | Sell | S | 211.90 | 1,726 | 365,741 | 110,302,100 | 110.3 M to 110.3 M (0.00 %) |